カテゴリ： 世界, 医療/バイオ, Market Monitor Global

ヒト用ワクチン接種のグローバル市場展望 2023年-2029年：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他

■ 英語タイトル：Human Vaccination Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8782）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8782
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：116
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヒト用ワクチン接種のグローバル市場展望 2023年-2029年：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のヒト用ワクチン接種市場規模と予測を収録しています。・世界のヒト用ワクチン接種市場：売上、2018年-2023年、2024年-2029年
・世界のヒト用ワクチン接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト用ワクチン接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「不活化ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト用ワクチン接種のグローバル主要企業は、GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 KM Biologics、 LG Life Sciences、 Serum Institute、 Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒト用ワクチン接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト用ワクチン接種市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン接種市場：タイプ別市場シェア、2022年
・不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他

世界のヒト用ワクチン接種市場：用途別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン接種市場：用途別市場シェア、2022年
・政府機関、民間企業、その他

世界のヒト用ワクチン接種市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト用ワクチン接種のグローバル売上、2018年-2023年
・主要企業におけるヒト用ワクチン接種のグローバル売上シェア、2022年
・主要企業におけるヒト用ワクチン接種のグローバル販売量、2018年-2023年
・主要企業におけるヒト用ワクチン接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 KM Biologics、 LG Life Sciences、 Serum Institute、 Pfizer

*************************************************************

・調査・分析レポートの概要
ヒト用ワクチン接種市場の定義
市場セグメント
世界のヒト用ワクチン接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト用ワクチン接種市場規模
世界のヒト用ワクチン接種市場規模：2022年 VS 2029年
世界のヒト用ワクチン接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト用ワクチン接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト用ワクチン接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他
ヒト用ワクチン接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：政府機関、民間企業、その他
ヒト用ワクチン接種の用途別グローバル売上・予測

・地域別市場分析
地域別ヒト用ワクチン接種市場規模 2022年と2029年
地域別ヒト用ワクチン接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 KM Biologics、 LG Life Sciences、 Serum Institute、 Pfizer
...

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or “wild” pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
This report aims to provide a comprehensive presentation of the global market for Human Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccination. This report contains market size and forecasts of Human Vaccination in global, including the following market information:
Global Human Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Human Vaccination companies in 2022 (%)
The global Human Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Inactivated Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Vaccination include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Vaccination Market Segment Percentages, by Type, 2022 (%)
Inactivated Vaccine
Live-attenuated Vaccine
mRNA Vaccine
Conjugate Vaccine
Other
Global Human Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Vaccination Market Segment Percentages, by Application, 2022 (%)
Government Institution
Private Sector
Other
Global Human Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Vaccination revenues share in global market, 2022 (%)
Key companies Human Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Human Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Vaccination, market overview.
Chapter 2: Global Human Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Human Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Human Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Vaccination Overall Market Size
2.1 Global Human Vaccination Market Size: 2022 VS 2029
2.2 Global Human Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Human Vaccination Players in Global Market
3.2 Top Global Human Vaccination Companies Ranked by Revenue
3.3 Global Human Vaccination Revenue by Companies
3.4 Global Human Vaccination Sales by Companies
3.5 Global Human Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Vaccination Market Size Markets, 2022 & 2029
4.1.2 Inactivated Vaccine
4.1.3 Live-attenuated Vaccine
4.1.4 mRNA Vaccine
4.1.5 Conjugate Vaccine
4.1.6 Other
4.2 By Type – Global Human Vaccination Revenue & Forecasts
4.2.1 By Type – Global Human Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Human Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Human Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Human Vaccination Sales & Forecasts
4.3.1 By Type – Global Human Vaccination Sales, 2018-2023
4.3.2 By Type – Global Human Vaccination Sales, 2024-2029
4.3.3 By Type – Global Human Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Human Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Vaccination Market Size, 2022 & 2029
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application – Global Human Vaccination Revenue & Forecasts
5.2.1 By Application – Global Human Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Human Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Human Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Human Vaccination Sales & Forecasts
5.3.1 By Application – Global Human Vaccination Sales, 2018-2023
5.3.2 By Application – Global Human Vaccination Sales, 2024-2029
5.3.3 By Application – Global Human Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Human Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Human Vaccination Revenue & Forecasts
6.2.1 By Region – Global Human Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Human Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Human Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Human Vaccination Sales & Forecasts
6.3.1 By Region – Global Human Vaccination Sales, 2018-2023
6.3.2 By Region – Global Human Vaccination Sales, 2024-2029
6.3.3 By Region – Global Human Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Human Vaccination Sales, 2018-2029
6.4.3 US Human Vaccination Market Size, 2018-2029
6.4.4 Canada Human Vaccination Market Size, 2018-2029
6.4.5 Mexico Human Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Human Vaccination Sales, 2018-2029
6.5.3 Germany Human Vaccination Market Size, 2018-2029
6.5.4 France Human Vaccination Market Size, 2018-2029
6.5.5 U.K. Human Vaccination Market Size, 2018-2029
6.5.6 Italy Human Vaccination Market Size, 2018-2029
6.5.7 Russia Human Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Human Vaccination Market Size, 2018-2029
6.5.9 Benelux Human Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Human Vaccination Sales, 2018-2029
6.6.3 China Human Vaccination Market Size, 2018-2029
6.6.4 Japan Human Vaccination Market Size, 2018-2029
6.6.5 South Korea Human Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Human Vaccination Market Size, 2018-2029
6.6.7 India Human Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Human Vaccination Sales, 2018-2029
6.7.3 Brazil Human Vaccination Market Size, 2018-2029
6.7.4 Argentina Human Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Vaccination Sales, 2018-2029
6.8.3 Turkey Human Vaccination Market Size, 2018-2029
6.8.4 Israel Human Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Human Vaccination Market Size, 2018-2029
6.8.6 UAE Human Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Human Vaccination Major Product Offerings
7.1.4 GSK Human Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Human Vaccination Major Product Offerings
7.2.4 Merck Human Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Vaccination Major Product Offerings
7.3.4 Sanofi Human Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Sinovac
7.4.1 Sinovac Company Summary
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Human Vaccination Major Product Offerings
7.4.4 Sinovac Human Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 Sinovac Key News & Latest Developments
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Company Summary
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Human Vaccination Major Product Offerings
7.5.4 Zhejiang Pukang Human Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 Zhejiang Pukang Key News & Latest Developments
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Company Summary
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Human Vaccination Major Product Offerings
7.6.4 Changchun Institute of Biological Human Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Changchun Institute of Biological Key News & Latest Developments
7.7 KM Biologics
7.7.1 KM Biologics Company Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Human Vaccination Major Product Offerings
7.7.4 KM Biologics Human Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 KM Biologics Key News & Latest Developments
7.8 IMBCAMS
7.8.1 IMBCAMS Company Summary
7.8.2 IMBCAMS Business Overview
7.8.3 IMBCAMS Human Vaccination Major Product Offerings
7.8.4 IMBCAMS Human Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 IMBCAMS Key News & Latest Developments
7.9 Convac
7.9.1 Convac Company Summary
7.9.2 Convac Business Overview
7.9.3 Convac Human Vaccination Major Product Offerings
7.9.4 Convac Human Vaccination Sales and Revenue in Global (2018-2023)
7.9.5 Convac Key News & Latest Developments
7.10 NCPC
7.10.1 NCPC Company Summary
7.10.2 NCPC Business Overview
7.10.3 NCPC Human Vaccination Major Product Offerings
7.10.4 NCPC Human Vaccination Sales and Revenue in Global (2018-2023)
7.10.5 NCPC Key News & Latest Developments
7.11 Bio Kangtai
7.11.1 Bio Kangtai Company Summary
7.11.2 Bio Kangtai Human Vaccination Business Overview
7.11.3 Bio Kangtai Human Vaccination Major Product Offerings
7.11.4 Bio Kangtai Human Vaccination Sales and Revenue in Global (2018-2023)
7.11.5 Bio Kangtai Key News & Latest Developments
7.12 Dynavax
7.12.1 Dynavax Company Summary
7.12.2 Dynavax Human Vaccination Business Overview
7.12.3 Dynavax Human Vaccination Major Product Offerings
7.12.4 Dynavax Human Vaccination Sales and Revenue in Global (2018-2023)
7.12.5 Dynavax Key News & Latest Developments
7.13 Hissen
7.13.1 Hissen Company Summary
7.13.2 Hissen Human Vaccination Business Overview
7.13.3 Hissen Human Vaccination Major Product Offerings
7.13.4 Hissen Human Vaccination Sales and Revenue in Global (2018-2023)
7.13.5 Hissen Key News & Latest Developments
7.14 KM Biologics
7.14.1 KM Biologics Company Summary
7.14.2 KM Biologics Business Overview
7.14.3 KM Biologics Human Vaccination Major Product Offerings
7.14.4 KM Biologics Human Vaccination Sales and Revenue in Global (2018-2023)
7.14.5 KM Biologics Key News & Latest Developments
7.15 LG Life Sciences
7.15.1 LG Life Sciences Company Summary
7.15.2 LG Life Sciences Business Overview
7.15.3 LG Life Sciences Human Vaccination Major Product Offerings
7.15.4 LG Life Sciences Human Vaccination Sales and Revenue in Global (2018-2023)
7.15.5 LG Life Sciences Key News & Latest Developments
7.16 Serum Institute
7.16.1 Serum Institute Company Summary
7.16.2 Serum Institute Business Overview
7.16.3 Serum Institute Human Vaccination Major Product Offerings
7.16.4 Serum Institute Human Vaccination Sales and Revenue in Global (2018-2023)
7.16.5 Serum Institute Key News & Latest Developments
7.17 Pfizer
7.17.1 Pfizer Company Summary
7.17.2 Pfizer Business Overview
7.17.3 Pfizer Human Vaccination Major Product Offerings
7.17.4 Pfizer Human Vaccination Sales and Revenue in Global (2018-2023)
7.17.5 Pfizer Key News & Latest Developments
8 Global Human Vaccination Production Capacity, Analysis
8.1 Global Human Vaccination Production Capacity, 2018-2029
8.2 Human Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Vaccination Supply Chain Analysis
10.1 Human Vaccination Industry Value Chain
10.2 Human Vaccination Upstream Market
10.3 Human Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 日本脳炎ウイルスワクチンのグローバル市場展望 2023年-2029年：不活化ワクチン、弱毒化生ワクチン
  • 鶏用ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン、
  • 鶏ニューカッスル病ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン
  • 豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン
  • mRNAワクチン＆治療薬の世界市場 2022年-2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8782 )"ヒト用ワクチン接種のグローバル市場展望 2023年-2029年：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他" (英文：Human Vaccination Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。